Literature DB >> 12234606

Modulation of agonist responses at the A(1) adenosine receptor by an irreversible antagonist, receptor-G protein uncoupling and by the G protein activation state.

Anna Lorenzen1, Margot W Beukers, Piet Hein van der Graaf, Heidrun Lang, Jacqueline van Muijlwijk-Koezen, Miriam de Groote, Wiro Menge, Ulrich Schwabe, Adriaan P IJzerman.   

Abstract

Potency and intrinsic activity of agonists depend on ligand structure, but are also regulated by receptor-G protein stoichiometry. A potential functional reserve in adenosine A(1) receptor-mediated G protein activation was investigated by stimulation of guanosine-5'-(gamma-[35S]thio)-triphosphate ([35S]GTPgammaS) binding by the full agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) and the partial agonist 5'-deoxy-5'-methylthioadenosine (MeSA). Pretreatment of rat brain membranes with the irreversible antagonist 1-propyl-3-[3-[[4-(fluorosulfonyl)benzoyl]oxy]-propyl]-8-cyclopentylxanthine revealed no classical receptor reserve for either agonist. The functional significance of the G protein coupling state of the receptor and occupancy of G proteins by guanine nucleotides was assessed after partial uncoupling of receptor-G protein complexes with N-ethylmaleimide and in the presence of increasing GDP concentrations. Agonist EC(50) values in G protein activation were increased after NEM pretreatment and at higher GDP concentrations, and a decrease in the relative intrinsic activity of MeSA was observed. The shift of agonist concentration-response curves to the right, the decrease in maximal effects and the decrease in relative intrinsic activity of the partial agonist point to a functional reserve which has to be attributed to GDP-free receptor-G protein complexes. The mechanisms of action of FSCPX, NEM and GDP were fully consistent with the two-state model of receptor activation. The apparent reserve revealed by GDP reflects a shift from spontaneously active GDP-free receptor-G protein complexes (RG)(*), which can bind [35S]GTPgammaS, to (RG) occupied by GDP. The abundance of (RG)(*) is favored by agonists and by the absence of GDP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234606     DOI: 10.1016/s0006-2952(02)01293-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.

Authors:  Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

Review 2.  Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.

Authors:  Rafael Franco
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

3.  Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.

Authors:  S Nijmeijer; H Engelhardt; S Schultes; A C van de Stolpe; V Lusink; C de Graaf; M Wijtmans; E E J Haaksma; I J P de Esch; K Stachurski; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  A covalent antagonist for the human adenosine A2A receptor.

Authors:  Xue Yang; Guo Dong; Thomas J M Michiels; Eelke B Lenselink; Laura Heitman; Julien Louvel; Ad P IJzerman
Journal:  Purinergic Signal       Date:  2016-12-03       Impact factor: 3.765

Review 5.  Chemical Probes for the Adenosine Receptors.

Authors:  Stephanie Federico; Lucia Lassiani; Giampiero Spalluto
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-12

6.  Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates.

Authors:  Athena M Klutz; Zhan-Guo Gao; John Lloyd; Asher Shainberg; Kenneth A Jacobson
Journal:  J Nanobiotechnology       Date:  2008-10-23       Impact factor: 10.435

7.  FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

Authors:  Tamas Erdei; Adrienn Monika Szabo; Nora Lampe; Katalin Szabo; Rita Kiss; Judit Zsuga; Csaba Papp; Akos Pinter; Andras Jozsef Szentmiklosi; Zoltan Szilvassy; Bela Juhasz; Rudolf Gesztelyi
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.